| Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse S Taavitsainen, N Engedal, S Cao, F Handle, A Erickson, S Prekovic, ... Nature communications 12 (1), 5307, 2021 | 69 | 2021 |
| Time-resolved expression profiling of the nuclear receptor superfamily in human adipogenesis M Lahnalampi, M Heinäniemi, L Sinkkonen, M Wabitsch, C Carlberg PLoS One 5 (9), e12991, 2010 | 36 | 2010 |
| Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable … J Mehtonen, S Teppo, M Lahnalampi, A Kokko, R Kaukonen, L Oksa, ... Genome Medicine 12, 1-25, 2020 | 25 | 2020 |
| SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome S Laukkanen, L Oksa, A Nikkilä, M Lahnalampi, M Parikka, M Seki, ... Leukemia & Lymphoma 61 (13), 3089-3100, 2020 | 5 | 2020 |
| In vivo interrogation of regulatory genomes reveals extensive quasi-insufficiency in cancer evolution A Fischer, R Lersch, N de Andrade Krätzig, A Strong, MJ Friedrich, ... Cell Genomics 3 (3), 2023 | 2 | 2023 |
| Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL G Gentile, T Poggio, A Catalano, M Voutilainen, M Lahnalampi, ... Blood Advances, 2024 | | 2024 |
| Sequential drug treatment targeting cell cycle and cell fate regulatory programs blocks non-genetic cancer evolution in acute lymphoblastic leukemia A Malyukova, M Lahnalampi, T Falqués-Costa, P Pölönen, M Sipola, ... bioRxiv, 2023.03. 27.534308, 2023 | | 2023 |
| Mechanistic Study of Wee1 Kinase Inhibition with AZD1775 Exposes Drug Targetable Vulnerabilities in Acute B-Lymphoblastic Leukemia A Malyukova, M Lahnalampi, T Falqués, P Pölönen, M Sipola, ... Blood 140 (Supplement 1), 11576-11576, 2022 | | 2022 |
| Dynamic Evolution of TCF3-PBX1 Leukaemias at Single Cell Level under Chemotherapy Pressure M Kusterer, M Lahnalampi, M Voutilainen, G Gentile, G Greve, S Pennisi, ... ONCOLOGY RESEARCH AND TREATMENT 45 (SUPPL 2), 30-30, 2022 | | 2022 |
| Single-cell transcriptome and chromatin sequencing uncover gene expression and gene regulatory patterns associated with enzalutamide resistance S Taavitsainen, N Engedal, S Cao, F Handle, A Erickson, S Prekovic, ... Cancer Research 82 (12_Supplement), 401-401, 2022 | | 2022 |
| P328: DYNAMIC EVOLUTION OF TCF3-PBX1 LEUKEMIAS AT THE SINGLE-CELL LEVEL UNDER CHEMOTHERAPY PRESSURE M Kusterer, M Lahnalampi, M Voutilainen, G Gentile, S Pennisi, J Norona, ... HemaSphere 6, 228-229, 2022 | | 2022 |
| SIX6 is a TAL1-regulated transcription factor in T-cell acute lymphoblastic leukemia S Laukkanen, L Oksa, A Nikkilä, J Mehtonen, P Pölönen, M Lahnalampi, ... Cancer Research 80 (16_Supplement), 3588-3588, 2020 | | 2020 |
| Analysis of DNA structural variations in context of the gene regulatory landscape of pediatric ALL L Oksa, M Vouttilainen, T Vuorenmaa, S Laukkanen, M Lahnalampi, ... Cancer Research 78 (13_Supplement), 2078-2078, 2018 | | 2018 |
| Genome-Wide Analysis of the Regulatory Landscape in Different Pre-B-ALL Subtypes M Lahnalampi, J Mehtonen, S Teppo, S Laukkanen, L Oksa, M Muschen, ... Blood 130, 3807, 2017 | | 2017 |
| Single-cell ATAC and RNA sequencing reveal pre-existing and persistent subpopulations of cells associated with relapse of prostate cancer S Taavitsainen, N Engedal, S Cao, F Handle, S Prekovic, D Wetterskog, ... | | |
